Search Results - "Pickworth, Josephine"
-
1
Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients With Pulmonary Arterial Hypertension
Published in Arteriosclerosis, thrombosis, and vascular biology (01-01-2021)“…OBJECTIVE:To determine whether global reduction of CD68 macrophages impacts the development of experimental pulmonary arterial hypertension (PAH) and whether…”
Get full text
Journal Article -
2
MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension
Published in The Journal of clinical investigation (01-07-2016)“…Loss of the growth-suppressive effects of bone morphogenetic protein (BMP) signaling has been demonstrated to promote pulmonary arterial endothelial cell…”
Get full text
Journal Article -
3
A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach
Published in EBioMedicine (01-07-2021)“…Pulmonary arterial hypertension (PAH) is a rare but life shortening disease, the diagnosis of which is often delayed, and requires an invasive right heart…”
Get full text
Journal Article -
4
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension
Published in Nature communications (15-11-2019)“…Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Current treatments increase life expectancy but have limited impact on the progressive…”
Get full text
Journal Article -
5
Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension
Published in The Journal of experimental medicine (22-10-2012)“…Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by the progressive narrowing and occlusion of small pulmonary arteries…”
Get full text
Journal Article -
6
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
Published in BMC pulmonary medicine (02-03-2018)“…Aldosterone is a mineralocorticoid hormone critically involved in arterial blood pressure regulation. Although pharmacological aldosterone antagonism reduces…”
Get full text
Journal Article -
7
Soluble P-Selectin and von Willebrand Factor Rise in Healthy Volunteers Following Non-exertional Ascent to High Altitude
Published in Frontiers in physiology (16-02-2022)“…Reduced oxygen tensions experienced at high altitudes are thought to predispose to thrombosis, yet there are few studies linking hypoxia, platelet activation,…”
Get full text
Journal Article -
8
-
9
Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling
Published in Pulmonary circulation (01-10-2017)“…Bone morphogenetic protein receptor type 2 (BMPR2) mutations are present in patients with heritable and idiopathic pulmonary arterial hypertension (PAH)…”
Get full text
Journal Article -
10
Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E−/− model of PAH and atherosclerosis
Published in Pulmonary circulation (01-01-2018)“…Idiopathic pulmonary arterial hypertension (IPAH) is increasingly diagnosed in elderly patients who also have an increased risk of co-morbid atherosclerosis…”
Get full text
Journal Article -
11
TRAIL Deficient Mice Are Protected from Sugen/Hypoxia Induced Pulmonary Arterial Hypertension
Published in Diseases (01-09-2014)“…Pulmonary arterial hypertension (PAH) is a progressive lung disease diagnosed by an increase in pulmonary arterial blood pressure that is driven by a…”
Get full text
Journal Article -
12
Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension
Published in Pulmonary circulation (01-01-2012)“…We previously reported that osteoprotegerin (OPG) is regulated by pathways associated with pulmonary arterial hypertension (PAH), and is present at elevated…”
Get full text
Journal Article -
13
-
14
Paigen Diet–Fed Apolipoprotein E Knockout Mice Develop Severe Pulmonary Hypertension in an Interleukin-1–Dependent Manner
Published in The American journal of pathology (01-10-2011)“…Inflammatory mechanisms are proposed to play a significant role in the pathogenesis of pulmonary arterial hypertension (PAH). Previous studies have described…”
Get full text
Journal Article -
15
Links Between Dysfunctional Bone Morphogenetic Protein Signalling and Interleukin-1ß Mediated Inflammation in Pulmonary Arterial Hypertension
Published 01-01-2017“…Rationale: Bone morphogenetic protein receptor type 2 (BMPR2) mutations are present in up to 70% of patients with heritable and up to 25% with idiopathic…”
Get full text
Dissertation -
16
Abstract 13921: Dysfunctional Bone Morphogenetic Protein Signaling Interlinks With Interleukin-1ß Mediated Inflammation in Pulmonary Arterial Hypertension
Published in Circulation (New York, N.Y.) (10-11-2015)“…RationaleBone morphogenetic protein receptor type 2 (BMPR2) mutations are found in heritable and idiopathic pulmonary arterial hypertension but disease…”
Get full text
Journal Article -
17
Abstract 11498: MicroRNA 140 Regulates Disease Phenotype in Experimental Pulmonary Arterial Hypertension And Identifies Smurf1 as a Novel Therapeutic Target
Published in Circulation (New York, N.Y.) (10-11-2015)“…RationaleClinical therapies for the treatment of pulmonary arterial hypertension (PAH) target vasoconstriction. However, the proliferative pulmonary vascular…”
Get full text
Journal Article -
18
Tumour necrosis factor-related apoptosis-inducing ligand is a novel therapeutic target in pulmonary arterial hypertension
Published in The Lancet (British edition) (27-02-2013)“…Abstract Background Pulmonary arterial hypertension is a fatal disease characterised by progressive narrowing of pulmonary arterioles, driven by aberrant…”
Get full text
Journal Article -
19
Selective improvement of pulmonary arterial hypertension with a dual ET A /ET B receptors antagonist in the apolipoprotein E −/− model of PAH and atherosclerosis
Published in Pulmonary circulation (01-01-2018)“…Idiopathic pulmonary arterial hypertension (IPAH) is increasingly diagnosed in elderly patients who also have an increased risk of co‐morbid atherosclerosis…”
Get full text
Journal Article -
20
Selective improvement of pulmonary arterial hypertension with a dual ET/ET receptors antagonist in the apolipoprotein E model of PAH and atherosclerosis
Published in Pulmonary circulation (01-01-2018)“…Idiopathic pulmonary arterial hypertension (IPAH) is increasingly diagnosed in elderly patients who also have an increased risk of co-morbid atherosclerosis…”
Get full text
Journal Article